Articles tagged with Cell Transplantation
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers found that fetal immune cells eliminate transplanted allogeneic blood cells, but only triggered by maternal breast milk antibodies. This limits engraftment following in utero hematopoietic cell transplantation.
Researchers have found that placenta-derived stem cells can reduce lung fibrosis and inflammation in mice with bleomycin-induced injury. The study's findings suggest these cells may be useful for cell therapy of fibrotic diseases in the future.
A recent study found that transplanted neurons develop disease-like pathology in Huntington's patients, raising concerns about the therapeutic potential of cell transplantation therapy. The research suggests new mechanisms involved in the development of the disease and offers a new direction for developing novel therapeutic strategies.
Researchers explore two bone marrow cell delivery methods to treat heart attacks and limb ischemia. Studies show that anterograde intra-coronary delivery improves left ventricle function, while bone marrow stem cell transplants increase blood flow in severely ischemic limbs.
Guided fat precursor cells lead to wider nerves and less muscle atrophy in injured peripheral nerves of laboratory rats. The study demonstrates the potential benefit of adult precursor cells, such as those from adipose tissue, for nerve repair and functional recovery.
Dr. Aileen Go has won a prestigious Amgen Foundation Fellowship grant to study treatment options for older leukemia and lymphoma patients. The research aims to develop a reduced-intensity chemotherapy regimen and methods to boost stem cells for patients aged 55-75.
Co-transplanting bone marrow stem cells with embryonic stem cells eliminates tumor formation in spinal cord injury (SCI) laboratory animals. The study suggests that BMSCs induce differentiation of undifferentiated ES cells into a neuronal lineage, resulting in suppression of tumor growth.
Researchers at UBC's Biomedical Research Centre have identified S1P as a molecule that can open the thymic gate for migrating stem cells. This discovery holds promise for increasing the success of blood stem cell transplants, which are currently used to treat diseases such as leukemia and aplastic anemia.
A new study found that transplanted liver cells from older donors work equally well in both young and old recipients, but have lower proliferation rates due to lower growth factor levels. The research suggests that injecting the growth factor IGF1 into older rats may increase hepatocyte cell proliferation.
Scientists have developed a device that protects transplanted pancreatic precursor cells from the immune system, allowing them to mature into functional beta cells. This breakthrough approach could alleviate the need for long-term immunosuppression in cell transplantation therapy.
A survey of US and Canadian pediatric hematopoietic cell transplant physicians found that only 50 out of thousands of transplants involved privately banked cord blood. The respondents generally recommended against private cord blood banking unless a family member is at risk for a blood disease requiring a stem cell transplant.
A new review by Johns Hopkins scientists highlights the importance of platelets in organ transplant rejection, revealing their role in driving inflammatory responses. This research could lead to the development of new strategies using drugs or other means to keep platelets quiet and non-inflammatory.
Researchers explore alternative anatomical sites for islet transplantation, including the pancreas, to improve engraftment potential and patient safety. Bioartificial pancreas engineering and encapsulation technologies are also being developed to overcome challenges in current transplantation methods.
Researchers at Albert Einstein College of Medicine developed a technique to make foreign pancreatic cells invisible to the immune system, dramatically protecting them from rejection. The new method could pave the way for routine use of cell transplants as a therapy for type 1 diabetes in humans.
Researchers investigate the effect of high blood sugar on the immune system in hopes of improving islet cell transplant success rates. High blood glucose levels can temporarily shift the balance between effector and regulatory T cells, giving advantage to regulatory cells that suppress attacks.
Scientists have successfully transplanted a single adult stem cell into a live mammal and shown that it can self-renew and repair damaged tissue. The study used genetically engineered cells to track their dynamics, demonstrating the ability of these cells to proliferate and engraft into injured muscle tissue.
Researchers have successfully transplanted de-differentiated fat (DFAT) cells into animal models, promoting functional recovery and motor function after spinal cord injury. The study suggests that DFAT cells could be a source for cell replacement therapy to treat central nervous system disorders.
Researchers successfully monitored transplanted stem cells using bioluminescent imaging and iron oxide, enabling non-invasive tracking. Three different labeling methods were evaluated for their reliability in detecting transplanted mensenchymal stem cells, with DAPI labeling showing promising results.
A new clinical trial has demonstrated the safety of expanding umbilical cord blood stem cells before transplanting them to patients with advanced leukemias or lymphomas. The study found that expanded stem cell technique is comparable to standard double-cord transplant and shows promise for improved engraftment and survival.
Two studies examine the impact of cord blood, peripheral blood, and bone marrow on transplant success rates in adults with acute leukemia. The research reveals that mismatched cord blood transplants can be a suitable alternative to bone marrow or peripheral blood transplants.
Researchers at Northwestern University found a way to trick the immune system of mice into believing transplanted islets are their own cells. This technique eliminated the need for immunosuppressive drugs in mice with chemically-induced diabetes after islet transplantation, showing high success rates.
Researchers found that direct implantation of mesenchymal stem cells did not remyelinate the damaged area, but still consider MSCs a promising tool for neurological disorders due to their pre-clinical efficacy in treating stroke and MS.
Researchers have discovered that alpha-1-antitrypsin (AAT) can eliminate inflammation in diabetic animals after islet transplantation, allowing the transplanted cells to survive and function for over 120 days. This breakthrough could lead to a safer and more effective treatment for type-1 diabetes patients.
Researchers have discovered two types of astrocyte support cells generated from a common stem cell-like precursor cell, one effective at promoting nerve regeneration and the other causing neuropathic pain. The study offers a promising approach to repairing spinal cord injuries without inducing pain syndromes.
Researchers found that immune-defense cells influenced by embryonic stem cell-derived cells can prevent transplant rejection in mice. The study's results suggest a potential method for reducing the need for immunosuppressive drugs in human organ and bone marrow transplants.
Researchers found that combining adult cardiomyocytes with bone marrow cells enhances therapeutic effects and reduces programmed cell death. The technique shows promise as a new strategy for myocardial repair, with potential applications in cardiac tissue regeneration.
Researchers found that transplantation of human cord blood cells can repair cochlear damage in animal models, with dramatic repair observed despite few human-derived cells migrating to the cochlea. The study suggests a potential treatment strategy for inner ear rehabilitation and hearing impairments caused by cochlear damage.
A study of 50 healthy adult men found that black non-sensitized males had an average of 17.2% more HLA-sensitive B cells than white non-sensitized males, increasing their opportunity for antibody-mediated rejection. This increased number of B cells may be customized in treatments to lessen the likelihood of organ rejection.
A nationwide clinical trial is underway to investigate the use of unrelated donor marrow and cord blood transplants for severe sickle cell disease. The trial, facilitated by the Blood and Marrow Transplant Clinical Trials Network, aims to extend a promising treatment option to more severely affected patients.
Researchers have developed a groundbreaking procedure using tailor-made regulatory cells to avoid lifelong drug use for transplant patients. The technique shows promising findings and has been tested in clinical trials on 17 kidney transplant patients, with encouraging results.
Researchers at the University of Florida have identified a molecular signature based on gene expression that can predict the development of acute graft-versus-host disease (GVHD) in patients receiving liver stem cell transplants. This could lead to better biomarkers for determining patient risk and improving treatment outcomes.
Researchers have found that human umbilical cord blood cells can improve liver damage and function in rats with hepatitis. The study provides an alternative to bone marrow transplants for hepatic regenerative medicine, offering hope for patients suffering from terminal hepatic failure.
Researchers have genetically programmed embryonic stem cells to become nerve cells when transplanted into the brain, resulting in tangible therapeutic improvement in mice with stroke. The new nerve cells integrate into the existing network and provide cognitive benefits.
Transplanting human umbilical cord blood cells into mouse models with ALS delayed disease symptom progression and increased lifespan. The moderate-strength dose of HUCB cells proved most effective in providing neuroprotection for motor neurons.
Researchers at UNC have shown that transplantation of adult stem cells can improve healing of fractures in animal models. The study provides a scientific foundation for future clinical trials and could lead to a new treatment for millions of people suffering from bone union failure.
University of Illinois Chicago researchers modified the procedure for islet cell transplantation and achieved insulin independence in diabetes patients using fewer but better-functioning pancreatic islet cells. The study results are published in the American Journal of Transplantation.
Researchers have identified cells that initiate infant tumors, developing a new mouse model to identify therapeutic targets. A molecule called IRF4 has been found to control inflammation in the gut, while implanting olfactory ensheathing cells promotes neuroplasticity in stroke models.
Researchers have made significant progress in developing neural cell transplants as a potential treatment for Parkinson's disease. Engineered human neural progenitor cells that produce glial-derived neurotrophic factor (GDNF) show promise in promoting functional recovery and improving motor function without causing negative side effects.
A new non-invasive method to determine tumor oxygen levels and image surrounding tissues has been developed, offering promising insights into tumor development. Researchers suggest that this approach could lead to improved diagnosis and treatment strategies for tumors and other diseases.
Researchers at Penn have engineered living human nerve cells into a network that can be transplanted to repair damaged nerves. The three-dimensional neural network, created through the stretch growth technique, maintained its geometry and function after transplantation.
Scientists discovered that HOXA11, a homeobox gene, is essential for the development of uterosacral ligaments, which are weakened in women with pelvic organ prolapse. In another study, researchers found that increased expression of the WNT antagonist sFRP-1 contributes to elevated intraocular pressure in glaucoma patients.
A team of scientists has successfully derived functional immune system blood cells from embryonic stem cells using HOXB4 protein. The study showed that the transplanted cells were able to respond effectively to viruses and vaccines, demonstrating a promising new approach for patients with severe blood and immune disorders.
Researchers found that human mesenchymal stem cells (hMSCs) and bone marrow stromal cells (BMSCs) can migrate to damaged brain tissue after a stroke, improving neural function. The transplanted cells may also enhance tissue repair and functional recovery.
Researchers are enrolling patients in a new study that transplants stem cells from a kidney donor's bone marrow into the recipient, with the goal of gradually eliminating the need for antirejection drugs. The study aims to improve post-transplant quality of life for recipients.
Researchers are conducting a US trial using purified adult stem cells to treat critical limb ischemia, a condition that affects 1.4 million people and can lead to amputation. The study aims to grow new blood vessels and restore circulation in legs with severely blocked arteries.
Researchers have made significant progress in cardiac stem cell therapy, exploring novel delivery methods and strategies to improve cell survival. These advancements aim to overcome the challenges of poor vascular supply and inflammation after a heart attack, paving the way for more effective treatments.
Researchers at the University of Texas M. D. Anderson Cancer Center report that a milder chemotherapy regimen before stem cell transplant resulted in complete remission for 45 of 47 patients with relapsed follicular lymphoma. Long-term follow-up showed improved overall survival and progression-free survival rates.
Researchers at Kyoto University School of Medicine successfully regenerated damaged nerves using bone marrow cells containing adult stem cells. The transplanted cells differentiated into Schwann cells, promoting axon regeneration and healthier vascularity.
Researchers at Stanford University School of Medicine have successfully transplanted new blood-forming stem cells into the bone marrow of mice, effectively replacing their immune systems. This technique could potentially treat autoimmune and genetic blood diseases by introducing a healthy immune system.
Researchers found that skeletal myoblasts can help improve urinary incontinence in female rats with urethral sphincter deficiency when transplanted into their nerve-damaged muscles. The transplanted muscle cells increased urethral pressure, leading to significant improvement in incontinence and near-normal urethral closure pressures.
Scientists have successfully transplanted embryonic pig pancreatic cells into diabetic macaque monkeys, reducing the need for insulin injections without immune suppression. The transplants showed promise for curing type 1 and type 2 diabetes in humans with additional research.
Central nervous system infections are a rare but significant predictor of death among heart transplant recipients. According to a study of 315 patients, 8 developed CNS infections within four years after transplantation, resulting in three deaths and two survivors with mild complications.
Researchers at UT Southwestern Medical Center found that dietary fats can kill transplanted pancreas cells, leading to a decline in insulin production. Limiting fat formation might make pancreatic cell transplants more effective.
A UCF team led by Kiminobu Sugaya has discovered a compound, phenserine, that reduces plaque buildup in Alzheimer's disease. This combination with stem cell transplantation triggers neuron regeneration, offering hope for patients. Further research, including clinical trials, is needed to confirm its effectiveness.
Scientists at Cold Spring Harbor Laboratory have successfully used uniparental embryonic stem cells to replace blood stem cells in immunocompromised adult mice. The study demonstrates the potential of androgenetic as well as parthenogenetic ES cells for regenerative medicine applications.
Researchers have successfully transplanted human nerve stem cells into rats' damaged spinal cords, which survived, grew, and formed connections with native cells. The breakthrough establishes a new doctrine for regenerative neuroscience, suggesting the spinal cord can support transplanted cell development.
Researchers found lower transplant rates in African-Americans compared to Caucasians, even when using self-donated or relative-donated stem cells. The discrepancy may be attributed to various factors, including differences in insurance coverage, cultural attitudes, and physician biases.
Researchers have discovered that transplanted neural stem cells can survive, differentiate into neurons, and form synapses with host tissue, potentially offering a new treatment for Parkinson's disease. The study shows promise in reducing the destruction of dopaminergic cells and replacing those lost to the disease.
A new study found that hematopoietic stem cell transplant (HSCT) recipients face a significant long-term risk of developing a second cancer, with the risk almost doubling within 10 years. The study also identified specific risk factors, including age at transplant and donor cell type.
Researchers have proven that tumours can be prevented from forming when embryonic stem cells are transplanted into laboratory animals. The team used microencapsulation technology to achieve this result, paving the way for vital therapies for disorders like diabetes.